GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New GERD drug tegoprazan tested in large real-world study
Disease control Recruiting nowThis study investigates the safety and symptom-relieving effects of the drug Tegoprazan (K-CAB) in adults with gastroesophageal reflux disease (GERD). Researchers will track how well the drug reduces heartburn and acid reflux after 4 weeks of use. The study includes over 5,000 pa…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Sponsor: HK inno.N Corporation • Aim: Disease control
Last updated Jul 02, 2026 08:00 UTC
-
New app aims to help GERD patients stick to treatment
Disease control Recruiting nowThis study tests whether a smartphone app called GERDCare can help people with GERD (acid reflux) take their medication and follow lifestyle advice more consistently. About 380 adults with typical reflux symptoms will use the app for four weeks, and researchers will measure how w…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: Institute of Gastroenterology and Hepatology, Vietnam • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New GERD drug shows promise in major trial
Disease control Recruiting nowThis study tests a new medication, linaprazan glurate, to see if it heals esophagus damage from acid reflux better than a standard drug. About 500 adults with erosive esophagitis will take either the new drug or lansoprazole daily for up to 8 weeks. Doctors will use cameras to ch…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New surgical approach aims to spare nerves and improve life for GERD patients
Disease control Recruiting nowThis study compares a new nerve-sparing surgery (TLSA) to the standard surgery for people with hiatal hernia and GERD. The goal is to see if the new approach improves quality of life by avoiding damage to a key nerve. About 143 adults will take part in this randomized trial.
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Zap away heartburn? new device aims to tame GERD without drugs
Symptom relief Recruiting nowThis study tests a device called eGERD that sends mild electrical pulses to the belly to reduce acid reflux and symptoms like heartburn. 84 adults with GERD will use either the real device or a sham version at home for several weeks. Researchers will measure acid levels in the th…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: Gerd Care Medical Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC